|
|
|
Volumn 16, Issue 7, 2003, Pages 31-36
|
|
A comparison of costs for four oral antidiabetic regimens within a managed care population
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GLIBENCLAMIDE;
METFORMIN;
REPAGLINIDE;
CONTROLLED STUDY;
DIABETES MELLITUS;
DRUG COST;
DRUG EFFICACY;
DRUG USE;
FEMALE;
HEALTH CARE COST;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MANAGED CARE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
RETROSPECTIVE STUDY;
REVIEW;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADULT;
AGED;
CALIFORNIA;
CARBAMATES;
COHORT STUDIES;
DATA INTERPRETATION, STATISTICAL;
DIABETES MELLITUS, TYPE 2;
DRUG THERAPY, COMBINATION;
FEMALE;
GLYBURIDE;
HEALTH CARE COSTS;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN;
INSURANCE CLAIM REVIEW;
MALE;
MANAGED CARE PROGRAMS;
METFORMIN;
MIDDLE AGED;
PIPERIDINES;
RETROSPECTIVE STUDIES;
|
|
EID: 0041843873
PISSN: 10965645
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (6)
|
